News

Public · Published

SCL: Q3 growth broadened across segments as higher savings and deleveraging targets strengthened the 2026 outlook

SCL reported third-quarter adjusted EBITDA of $66.3 million, up 18%, with 7% organic volume growth across all segments. Management expects 2026 adjusted EBITDA growth, positive free cash flow and continued deleveraging, while raising Project Catalyst savings expectations.

Published:

Updated:

What happened

SCL reported third-quarter adjusted EBITDA of $66.3 million, up 18%, with 7% organic volume growth across all segments. Management expects 2026 adjusted EBITDA growth, positive free cash flow and continued deleveraging, while raising Project Catalyst savings expectations.

Confirmed

Global impact / market context

Higher savings and debt reduction mean more cash available, which means the company keeps more of each sale and owes less borrowed money. That can support future capital spending and make profit less sensitive to weaker demand, strengthening the 2026 outlook.

Analyst inference

Broad volume growth across every segment suggests demand is holding up rather than coming from one strong area. Investors commonly weigh steadier sales plus rising savings and debt reduction as signs of more durable earnings, which can affect how they position in the stock.

Analyst inference

What to watch

  1. Management expects 2026 adjusted EBITDA growth and positive free cash flow, which means cash from operations after capital spending stays above zero, alongside continued deleveraging, meaning further reduction of borrowed money. Confirmed
  2. Watch whether Project Catalyst savings targets keep being raised and whether those savings show up as lower costs or higher profit per sale in future reports rather than only as stated expectations. Proposed
  3. Watch whether 7% organic volume growth, which means growth excluding acquisitions and currency effects, continues across all segments, since a slowdown in any one segment would weaken the broad-based demand picture. Analyst inference

Evidence

  • Original source link unavailable